Atwater Malick’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Buy
655
+11
+2% +$4.38K 0.06% 105
2026
Q2
$233K Buy
+644
New +$220K 0.05% 112
2019
Q4
– Sell
-200
Closed -$39K – 44
2019
Q3
$39K Buy
+200
New +$38.4K 0.03% 80

Other funds holding AMGN

Atwater Malick's AMGN Position: Q3 2026 in Review

Atwater Malick increased its Amgen (AMGN) stake by 1.7% in Q3 2026, buying an estimated $4.38K and bringing the position to 655 shares worth $276K. The position accounts for 0.06% of the portfolio, ranked #105.

Atwater Malick first reported a position in AMGN in Q3 2019 and has held it in 3 quarters since. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Atwater Malick held 655 shares of Amgen worth $276K as of Q3 2026.
  • Atwater Malick bought 11 Amgen shares in Q3 2026, an estimated $4.38K.
  • Amgen made up 0.06% of Atwater Malick's portfolio in Q3 2026, its #105 holding.
  • Atwater Malick first reported a position in Amgen in Q3 2019 and has held it in 3 quarters since.
  • 2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Atwater Malick's 13F filing for Q3 2026, filed 15 Oct 2026.